VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vector1 who wrote (6001)	11/23/1998 12:36:00 PM
From: David Cathcart	Read Replies (1) of 9719

MOGN is continuing it upward move on solid volume. It hit double figures today for the first time in months, though it is now trading around 9 7/8. Last week's news release regarding the beginning of the phase II trial for pancreatic cancer started this move. They will announce the beginning of the ovarian cancer phase II trial before the end of the year. I know that MOGN was purchased in this portfolio primarily because of the promise of Salagen. MGI 114 seems to be upstaging it now though. I found the pancreatic cancer phase II trial news release very positive. Anyone care to comment on this news and any caveats? David

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next